InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Seelenberger Alexander A., Chief Financial Officer. Officer active across 1 companies, notably Vincerx Pharma, Inc.. Aggregated, 4 reports have been published. Total volume traded: €213k. The latest transaction was disclosed on 22 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€22,1382,417 shares@ €9.15910.23% mcap20.8% of flow
Common Stock
SEC:0000899243-21-049773·
Ideal exit: 18 Sept 2022 (T+270)
€22,1382,417 shares@ €9.15910.23% mcap10.4% of flow
Common Stock
SEC:0000899243-21-049773:0·
Ideal exit: 18 Sept 2022 (T+270)
€84,2387,950 shares@ €10.5960.88% mcap79.2% of flow
Common Stock
SEC:0000899243-21-026817·
Ideal exit: 26 Mar 2022 (T+270)
€84,2387,950 shares@ €10.5960.88% mcap39.6% of flow
Common Stock
SEC:0000899243-21-026817:0·
Ideal exit: 26 Mar 2022 (T+270)
4 of 4 declarations
About Seelenberger Alexander A.
Seelenberger Alexander A. is the Chief Financial Officer at Vincerx Pharma, Inc. In this role, he is responsible for the financial management of the company, including budgeting and financial reporting. His expertise in finance is essential to support Vincerx's growth strategy. He plays a key role in developing the company's financial strategies.
